dc.contributor.author |
Kasimova S.A., Axatov Sh.Sh., Babadjanova Sh.A. |
|
dc.date.accessioned |
2023-05-10T16:21:08Z |
|
dc.date.available |
2023-05-10T16:21:08Z |
|
dc.date.issued |
2023-04 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/7783 |
|
dc.description.abstract |
In connection with the above, a burdened family history of
metabolic syndrome (especially if there is a phenotypic similarity between the
patient and a relative with MS) can be regarded as a risk factor for the
complication of "steroid diabetes mellitus". Patients assigned to this group, if
dexamethasone is necessary, should be pre-tested for glucose tolerance and
subsequently their blood glucose levels should be effectively monitored during
program treatment . |
en_US |
dc.language.iso |
other |
en_US |
dc.publisher |
KLINIK LABORATOR DIAGNOSTIKADA INNOVATSION TEXNOLOGIYALARDAN FOYDALANISH, MUAMMOLAR VA YECHIMLAR |
en_US |
dc.relation.ispartofseries |
№2; |
|
dc.subject |
Leukemia,lymphoblastic leukemia,glucocorticosteroid hormones,diabetes mellitus |
en_US |
dc.title |
Frequency of occurrence of steroid diabetes mellitus on the background of acute leukemia |
en_US |
dc.type |
Thesis |
en_US |